Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial

por Holzgreve, Adrien, Unterrainer, Marcus, Calais, Jérémie, Adams, Thaiza, Oprea-Lager, Daniela E., Goffin, Karolien, Lopci, Egesta, Unterrainer, Lena M., Kramer, Kristina K. M., Schmidt-Hegemann, Nina-Sophie, Casuscelli, Jozefina, Stief, Christian G., Ricke, Jens, Bartenstein, Peter, Kunz, Wolfgang G., Mehrens, Dirk
Publicado 2023